.In view of these facts, although extensive studies on the diverse bioactivity of 5-arylidene-rhodanines have been reported, but the anti-acetylcholinesterase (AChE) activities of these prototypes have never appeared in the literature. Accordingly in continuous of our studies in developing new anti-AChE agents, a series of 5-benzylidenerhodanine-3-acetamides bearing morpholino-, 4-arylpiperazinyl-, or 4-benzylpiperidinyl-moieties were synthesized and evaluated their inhibitory activity against acetylcholinesterase (AChE). Alteration of amide part and substitution on the benzylidene moiety resulted in changing of Anti-AChE activity. The most active compound was the 4-(3-fluorophenyl) piperazin-1-yl derivative 4h containing 3,4,5-trimethoxybenzylidene scaffold. Notably, the intermediate compounds namely 5-arylidene-rhodanine-3-acetic acids 3 showed mild inhibitory activity against 15-lipoxygenase (15-LOX), while the final compounds 4 showed no activity against 15-LOX. 
Alireza
.In view of these facts, although extensive studies on the diverse bioactivity of 5-arylidene-rhodanines have been reported, but the anti-acetylcholinesterase (AChE) activities of these prototypes have never appeared in the literature. Accordingly in continuous of our studies in developing new anti-AChE agents, a series of 5-benzylidenerhodanine-3-acetamides bearing morpholino-, 4-arylpiperazinyl-, or 4-benzylpiperidinyl-moieties were synthesized and evaluated their inhibitory activity against acetylcholinesterase (AChE). Alteration of amide part and substitution on the benzylidene moiety resulted in changing of Anti-AChE activity. The most active compound was the 4-(3-fluorophenyl) piperazin-1-yl derivative 4h containing 3,4,5-trimethoxybenzylidene scaffold. Notably, the intermediate compounds namely 5-arylidene-rhodanine-3-acetic acids 3 showed mild inhibitory activity against 15-lipoxygenase (15-LOX), while the final compounds 4 showed no activity against 15-LOX. 
